Anna Baghdasaryan

Graz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Efficacy and safety of pegzilarginase in patients below 2 years of age with arginase 1 deficiency: a phase 3, open-label, multi-centre study.

Efficacy and safety of pegzilarginase in patients below 2 years of age with arginase 1 deficiency: a phase 3, open-label, multi-centre study.

Journal: EClinicalMedicine

Published: March 27, 2026

Prevalence, Disease Onset and Clinical Outcome in Arginase 1 Deficiency: Cross-Border Surveillance in Germany, Austria, and Switzerland.

Prevalence, Disease Onset and Clinical Outcome in Arginase 1 Deficiency: Cross-Border Surveillance in Germany, Austria, and Switzerland.

Journal: Journal of inherited metabolic disease

Published: March 11, 2026

The genotypic and phenotypic landscape of PDHA1-related pyruvate dehydrogenase complex deficiency.

The genotypic and phenotypic landscape of PDHA1-related pyruvate dehydrogenase complex deficiency.

Journal: Brain : a journal of neurology

Published: July 01, 2025

The genotypic and phenotypic landscape of PDHA1-related pyruvate dehydrogenase complex deficiency.

The genotypic and phenotypic landscape of PDHA1-related pyruvate dehydrogenase complex deficiency.

Journal: Brain : a journal of neurology

Published: July 01, 2025

Hearing rehabilitation in SERAC1 related MEGD(H)EL syndrome - implications from a multi-center retrospective cohort study.

Hearing rehabilitation in SERAC1 related MEGD(H)EL syndrome - implications from a multi-center retrospective cohort study.

Journal: Molecular genetics and metabolism

Published: May 31, 2025

The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear.

The Benefit of Detecting Reduced Intracellular B12 Activity through Newborn Screening Remains Unclear.

Journal: International journal of neonatal screening

Published: May 12, 2024

Histological demonstration of BSEP/ABCB11 inhibition in transient neonatal cholestasis: a case report.

Histological demonstration of BSEP/ABCB11 inhibition in transient neonatal cholestasis: a case report.

Journal: BMC pediatrics

Published: November 22, 2019

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.

Journal: Journal of hepatology

Published: May 06, 2015

Clinical application of transcriptional activators of bile salt transporters.

Clinical application of transcriptional activators of bile salt transporters.

Journal: Molecular aspects of medicine

Published: September 18, 2013

Nuclear receptors as drug targets in cholestatic liver diseases.

Nuclear receptors as drug targets in cholestatic liver diseases.

Journal: Clinics in liver disease

Published: April 02, 2013

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.

Journal: Hepatology (Baltimore, Md.)

Published: March 07, 2013

Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment.

Primary sclerosing cholangitis: new approaches to diagnosis, surveillance and treatment.

Journal: Digestive diseases (Basel, Switzerland)

Published: October 19, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026